# Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)

> **NCT06822049** · PHASE2,PHASE3 · RECRUITING · sponsor: **State University of New York at Buffalo** · enrollment: 200 (estimated)

## Conditions studied

- Remote vs. In-Person
- Remote Visits
- In-person Visits

## Interventions

- **DRUG:** Combination Nicotine Replacement Therapy (patch and lozenge)

## Key facts

- **NCT ID:** NCT06822049
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822049, "Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06822049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*